Carey LA, Rugo HS, Marcom PK, et al. TBCRC 001: Randomized phase II study of cetuximab in combina tion with carboplatin in stage IV triple negative breast cancer. J Clin Oncol. 2012; 30:2615 -2623. 42. Rouzier R, Perou CM, Symmans WF, et al. Breast cancer molecular subt ypes respond differentl y to preoperative chemotherap y. Clin Cancer Res. 2005; 11:5678 -5685. 43. Harris LN, Broadwater G, L in NU, et al. Molecular subty pes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: Results from CAL GB 9342. Breast Cancer Res. 2006; 8:R66. 44.